What is FMC Science?
FMC Science operates as a specialized clinical trial research organization, maintaining a robust presence in Lampasas and Georgetown, Texas. By serving a demographic of over 80,000 residents, the company functions as a critical bridge between pharmaceutical innovation and patient care. Its core business model revolves around the rigorous execution of clinical studies, ensuring that safety protocols and data integrity remain at the forefront of medical development. As an independently owned entity, FMC Science leverages its localized expertise to facilitate the testing of next-generation treatments, effectively contributing to the global healthcare ecosystem by providing high-quality data for medical advancement.
How much funding has FMC Science raised?
FMC Science has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in FMC Science
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for FMC Science?
With the recent influx of capital, FMC Science is poised to transition into a more aggressive growth phase. The strategic allocation of these funds will likely focus on expanding its site footprint and enhancing its technological infrastructure to support more complex, large-scale clinical trials. By deepening its research capacity, the company aims to attract further partnerships with major pharmaceutical developers, thereby solidifying its role as a premier site for medical innovation. The focus remains on operational excellence and the continued recruitment of participants for critical health studies, ensuring that the firm remains at the cutting edge of clinical research services.
See full FMC Science company page
